QUANDO VOCÊ DEVE REPETIR O EXAME DE SANGUE PARA DETECTAR A TOXOPLASMOSE?

VOCÊ PODE DEVE COMPARECER AO SETOR DE COLETA DE MATERIAL, NO 2o ANDAR DO PRÉDIO DOS AMBULATÓRIOS, DAS 7 ÀS 11 HORAS DA MANHÃ, DE 2a A 6A FEIRA

VOCÊ PODE VIR TIRAR O SANGUE EM QUALQUER DIA DA SEMANA, PORÉM SOMENTE NAS SEMANAS QUE ESTIVEREM ASSINALADAS ABAIXO

No GRUPO MENSAL

Data:

1a COLETA: Do dia ____/____/____ até ____/____/____ 2a COLETA: Do dia ____/____/____ até ____/____/____ 3a COLETA: Do dia ____/____/____ até ____/____/____ 4a COLETA: Do dia ____/____/____ até ____/____/____ 5a COLETA: Do dia ____/____/____ até ____/____/____ 6a COLETA: Do dia ____/____/____ até ____/____/____ 7a COLETA: Do dia ____/____/____ até ____/____/____ 8a COLETA: Do dia ____/____/____ até ____/____/____

No GRUPO TRIMESTRAL Data: 1a COLETA: ____/____/____ até ____/____/____ 2a COLETA: ____/____/____ até ____/____/____ 3a COLETA: ____/____/____ até ____/____/____ Retorno: ____/____/____ na nutrição às 10:00h

SIGA CORRETAMENTE TODAS AS RECOMENDAÇÕES DO SEU MÉDICO DURANTE O PRÉ-NATAL, E VOCÊ TERÁ UMA GRAVIDEZ TRANQÜILA E UM BEBÊ SAUDÁVEL

congênita.

N GR NOME G P DUM DATA 1SORO IG 1SORO DATA OHD IG OHD SP SC DATA RET IG RET S 1 T VLS 2 1 23/11/92 12/04/93 20,0 31/05/93 27,0 2 1 14/07/93 33,0 S 2 M AB 1 0 31/10/92 19/01/93 11,0 31/05/93 30,0 3 3 23/06/93 33,0 S 3 T CSD 1 0 08/02/93 25/05/93 15,0 04/06/93 16,0 3 3 29/09/93 33,0 S 4 M NTM 5 1 20/03/93 25/05/93 9,0 07/06/93 11,0 7 7 03/11/93 32,0 S 5 M NLS 3 2 23/10/92 14/04/93 24,0 08/06/93 32,0 2 2 21/06/93 34,0 S 6 T GOF 4 2 11/02/93 12/04/93 8,0 14/06/93 17,0 3 2 / / 0,0 7 M GTF 1 0 15/01/93 12/04/93 12,0 21/06/93 22,0 4 1 / / 0,0 8 T JCM 2 1 14/12/92 25/05/93 23,0 21/06/93 27,0 2 2 / / 0,0 9 M AS 1 0 01/12/92 25/02/93 12,0 21/06/93 28,0 2 1 / / 0,0 10 T AF 1 0 24/12/92 08/02/93 6,0 22/06/93 25,0 2 2 16/08/93 33,0 S 11 M EP 2 0 06/01/93 28/05/93 20,0 22/06/93 23,0 4 4 30/08/93 33,0 S 12 T MDS 9 8 31/10/92 18/01/93 11,0 22/06/93 33,0 1 1 05/07/93 35,0 S 13 M MS 3 1 19/02/93 18/06/93 17,0 25/06/93 18,0 5 2 / / 0,0 14 T MSC 4 3 03/12/92 15/06/93 27,0 25/06/93 29,0 1 1 09/08/93 35,0 N 15 M JMVC 4 1 07/12/92 25/05/93 24,0 25/06/93 28,0 3 2 02/08/93 34,0 S 16 T SCSR 3 2 22/03/93 01/06/93 10,0 28/06/93 14,0 3 2 24/11/93 35,0 S 17 M RCFV 6 4 26/03/93 15/06/93 11,0 28/06/93 13,0 7 0 / / 0,0 18 M FCBM 2 1 05/03/93 25/05/93 11,0 28/06/93 16,0 6 4 03/11/93 34,0 S 19 T MACC 2 0 28/04/93 08/06/93 5,0 28/06/93 8,0 2 1 / / 0,0 20 M NPG 1 0 16/03/93 18/06/93 13,0 28/06/93 14,0 6 2 / / 0,0 21 T NMVS 3 2 25/01/93 08/06/93 19,0 05/07/93 23,0 2 1 / / 0,0 22 M AVSJ 6 3 30/04/93 08/06/93 5,0 05/07/93 9,0 8 4 / / 0,0 23 M APS 2 1 23/02/93 08/06/93 15,0 05/07/93 18,0 5 2 / / 0,0 24 T ECA 2 0 10/02/93 27/05/93 15,0 05/07/93 20,0 2 2 / / 0,0 25 M DBBO 3 2 04/02/93 15/06/93 18,0 05/07/93 21,0 5 2 29/09/93 33,0 S 26 T ERB 2 1 17/01/93 13/04/93 12,0 12/07/93 25,0 2 2 / / 0,0 27 M ESS 1 0 08/02/93 27/05/93 15,0 12/07/93 22,0 4 4 / / 0,0 28 T MPM 1 0 15/11/92 15/06/93 30,0 12/07/93 34,0 1 1 / / 0,0 29 M ACCM 2 1 26/03/93 17/06/93 11,0 12/07/93 15,0 5 3 / / 0,0 30 T SLSL 3 1 15/12/92 25/05/93 23,0 12/07/93 29,0 1 1 11/08/93 34,0 S 31 M RFE 2 0 17/04/93 14/06/93 8,0 12/07/93 12,0 7 7 08/12/93 33,0 S 32 T LABHB 5 3 14/02/93 22/06/93 18,0 19/07/93 22,0 2 2 13/10/93 34,0 S 33 M SJT 2 0 23/04/93 17/06/93 7,0 19/07/93 12,0 8 0 / / 0,0 34 T CP 2 1 26/12/92 26/05/93 21,0 19/07/93 29,0 1 1 18/08/93 33,0 S 35 M JMSC 1 0 23/12/92 15/03/93 11,0 19/07/93 29,0 3 3 18/08/93 34,0 S 36 T GIVO 2 0 02/03/93 27/05/93 12,0 19/07/93 19,0 2 1 / / 0,0 37 M HPS 1 0 07/04/93 21/06/93 10,0 19/07/93 14,0 6 6 01/12/93 34,0 S 38 T FN 2 1 23/11/92 27/05/93 26,0 21/07/93 34,0 1 0 / / 0,0 39 M LCC 3 2 14/12/92 15/06/93 26,0 26/07/93 32,0 1 1 / / 0,0 40 T SSS 4 3 26/03/93 17/06/93 11,0 26/07/93 17,0 3 3 10/11/93 32,0 S 41 M CLLAB 3 2 03/05/93 24/06/93 7,0 26/07/93 12,0 2 2 / / 0,0 42 T MRS 1 0 22/02/93 28/05/93 13,0 26/07/93 22,0 2 2 13/10/93 33,0 S 43 M JBS 2 1 14/02/93 22/06/93 18,0 26/07/93 23,0 4 0 / / 0,0 continua

44 T MSJ 2 1 09/02/93 18/06/93 18,0 27/07/93 24,0 2 2 29/09/93 33,0 S 45 M LA 2 0 03/01/93 27/05/93 20,0 09/08/93 31,0 2 2 25/08/93 33,0 S 46 T EMV 1 0 05/05/93 15/07/93 10,0 10/08/93 13,0 3 3 05/01/94 35,0 S 47 M ASM 2 0 14/04/93 07/06/93 7,0 11/08/93 17,0 6 4 08/12/93 34,0 S 48 T AA 1 0 25/01/93 30/07/93 26,0 18/08/93 29,0 1 1 / / 0,0 49 M VSD 2 0 10/04/93 27/05/93 6,0 18/08/93 18,0 5 2 / / 0,0 50 T RGGA 1 0 23/04/93 15/07/93 11,0 31/08/93 18,0 3 2 / / 0,0 51 T RAU 1 0 18/03/93 15/06/93 12,0 03/09/93 24,0 2 2 17/12/93 39,0 S 52 T LASS 1 0 10/04/93 24/06/93 10,0 08/09/93 21,0 2 1 / / 0,0 53 M ARAS 2 0 13/02/93 15/06/93 17,0 09/09/93 29,0 3 3 / / 0,0 54 T LZO 1 0 28/03/93 27/07/93 17,0 15/09/93 24,0 2 2 / / 0,0 55 M SNN 1 0 02/03/93 14/06/93 14,0 16/09/93 28,0 3 1 / / 0,0 56 T MPP 5 4 10/04/93 26/08/93 19,0 20/09/93 23,0 2 0 / / 0,0 57 M MFF 2 1 13/03/93 17/06/93 13,0 22/09/93 27,0 3 1 / / 0,0 58 T MDBRR 1 0 07/06/93 03/08/93 8,0 27/09/93 16,0 3 3 / / 0,0 59 T ESA 5 2 15/06/93 23/07/93 5,0 13/10/93 17,0 3 0 / / 0,0 60 M JFC 2 1 15/02/93 25/05/93 14,0 13/10/93 34,0 2 0 / / 0,0 61 M ISF 3 2 15/03/93 24/08/93 23,0 19/10/93 31,0 2 2 10/11/93 34,0 S 62 M MSL 1 0 09/04/93 17/06/93 9,0 03/11/93 29,0 3 2 / / 0,0 63 T AFLSC 3 1 01/07/93 30/09/93 13,0 04/11/93 18,0 2 1 / / 0,0 64 M DZS 2 0 14/05/93 13/09/93 17,0 04/11/93 24,0 4 3 / / 0,0 66 M SRS 2 1 19/07/93 14/10/93 12,0 09/11/93 16,0 6 4 07/03/94 33,0 S 66 T APC 1 0 20/04/93 19/10/93 26,0 10/11/93 29,0 1 1 / / 0,0 67 M MPEP 2 1 18/08/93 14/10/93 8,0 17/11/93 13,0 7 4 / / 0,0 68 T MG 1 0 10/07/93 25/10/93 15,0 18/11/93 18,0 2 1 / / 0,0 69 M AASD 1 0 15/08/93 25/10/93 10,0 22/11/93 14,0 1 1 / / 0,0 70 M MP 1 0 12/04/93 15/07/93 13,0 24/11/93 32,0 2 2 15/12/93 35,0 S 71 M RCSG 3 2 05/05/93 24/09/93 20,0 03/12/93 30,0 2 0 / / 0,0 72 T AVT 2 1 31/07/93 18/10/93 11,0 13/12/93 19,0 2 2 / / 0,0 73 M AMA 5 1 24/07/93 05/10/93 10,0 16/12/93 20,0 4 3 / / 0,0 74 T ARMS 3 2 26/08/93 04/11/93 10,0 27/12/93 17,0 3 1 / / 0,0 75 M AMSR 8 7 25/04/93 16/08/93 16,0 28/12/93 34,0 2 2 / / 0,0 76 T THCRO 2 0 17/08/93 11/11/93 12,0 02/02/94 24,0 2 1 / / 0,0 77 T NRS 1 0 26/07/93 05/10/93 10,0 04/02/94 27,0 2 1 / / 0,0 78 M RCFS 2 1 04/06/93 30/07/93 8,0 07/02/94 34,0 2 0 / / 0,0 79 T RCSR 3 2 27/06/93 30/11/93 22,0 08/02/94 32,0 1 1 / / 0,0 80 M SRS 5 1 04/09/93 25/10/93 7,0 10/02/94 22,0 5 1 / / 0,0 81 T MRRR 2 1 25/08/93 18/10/93 7,0 23/02/94 26,0 2 0 / / 0,0 82 M VCSC 4 0 27/09/93 09/12/93 10,0 24/02/94 21,0 5 1 / / 0,0 83 T MEM 4 3 09/11/93 06/01/94 8,0 24/02/94 15,0 2 0 / / 0,0 GR = GRUPO G = GESTA P = PARA

DUM = DATA DA ÚLTIMA MENSTRUAÇÃO 1SORO = PRIMEIRA SOROLOGIA

OHD = ORIENTAÇÕES HIGIÊNICO-DIETÉTICAS SP = SOROLOGIAS PEDIDAS

SC = SOROLOGIAS COLHIDAS RET = RETORNO

ANONYMOUS. Controversy breeds ignorance. [Letter]. BMJ 302:973-4, 1991.

ASPÖCK, H.; POLLAK, A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 84:32-8, 1992. Supplement.

BARUZZI, R.G. Contribution to the study of the toxoplasmosis epidemiology. Serologic survey about the indians of the upper Xingu river, central Brazil. Rev

Inst Med Trop São Paulo 12:93-104, 1976.

BESSIÈRES, M.H.; ROQUES, C.; BERREBI, A.; BARRE, V.; CAZAUX, M.; SÉGUÉLA, J.P. IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol 45:605-8, 1992.

CAMARGO, M.E.; LESER, P.G. ; LESER, W.S.P. Diagnostic information from serological tests in human toxoplasmosis. A comparative study of hemagglutination, complement fixation, IgG- and IgM-immunofluorecence tests in 3.572 serum samples. Rev Inst Med Trop São Paulo 18:215-26, 1976.

CAMARGO, M.E.; LESER, P.G.; LESER, W.S. Definição de perfís sorológicos na toxoplasmose: Importância diagnóstica e epidemiológica. Rev Bras Patol

Clin 13:113-27, 1977.

CAMARGO, M.E.; MOURA, M.E.G.; ; LESER, P.G. Toxoplasmosis serology: an efficient hemagglutination procedure to detect IgG and IgM antibodies. Rev Inst

Med Trop São Paulo 31:279-85, 1989.

CAMARGO, M.E.; SILVA, S.M.; LESER, P.G.; GRANATO, C.H. Avidez de anticorpos IgG específicos como marcadores de infecção primária recente pelo

Toxoplasma gondii. Rev Inst Med Trop São Paulo 33:213-8, 1991.

CARTER, A.O.; GELMON, S.B.; WELLS, G.A.; TOEPELL, A.P. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiol Infect 103:539-45, 1989.

CAZENAVE, J; FORESTIER, F.; BESSIÈRES, M.H.; BROUSSIN, B.; BEGUERET, J. Contribution of the P.C.R. to the prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn 2:119-28, 1992.

CHA S.C.; PEDREIRA D.A.L.; SANTOS V.A.; SAITO R.; FISZMAN M.; SANCOVSKI M.; ZUGAIB M. Infecções congênitas: Perfil sorológico das gestantes do HCFMUSP. Rev Ginecol Obstet 4:172-177, 1993.

CONYN-VAN SPENDONCK, M.A.E. Prevention of congenital toxoplasmosis: experience in the Netherlands. Int-Ophthalmol 13:403-6, 1989.

CONYN-VAN SPENDONCK, M.A.E. Prevention of congenital toxoplasmosis in the Netherlands. In: Bilthoven: National Institute of Public Health and

Environmental Protection, 1991. p.30-44.

COUTINHO, S.G.; SOUZA, W.J.S.; CAMILLO COURA, L.; MARZOCHI, M.C.A.; AMENDOEIRA, M.R.R. Levantamento dos resultados das reações de imunofluorescência indireta para toxoplasmose em 6079 pacientes de ambulatório ou gestantes no Rio de Janeiro, realizadas durante os anos de 1971 a 1977. Rev Inst Med Trop São Paulo 23:48-56, 1981.

COUVREUR, J.; THULLIEZ, Ph.; DAFFOS, F.; AUFRANT, Ch.; BOMPARD, Y.; GESQUIÈRE, A.; DESMONTS G. In utero treatment of toxoplasmic fetopathy with combination pyrimethamine-sulfadiazine. Fetal Diagn Ther 8:45-50, 1993.

DAFFOS, F.: FORESTIER, F.; CAPELLA-PAVLOVSKY, M.; THULLIEZ, Ph.; AUFRANT, C.; VALENTI, D; COX, W.L. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Eng J Med 318:271-5, 1988.

DECOSTER, A.; CARON, A.; DARCY, F.; CAPRON, A. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet 12:1104-7, 1988.

DESMONTS, G. Preventing congenital toxoplasmosis. Lancet 20:1017-8, 1990.

DESMONTS, G.; COUVREUR, J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Eng J Med 290:1110-16, 1974.

DESMONTS, G.; FORESTIER, F.; THULLIEZ, P.H.; DAFFOS, F.; CAPELLA- PAVLOVSKY, M.; CHARTIER, M. Prenatal diagnosis of congenital toxoplasmosis. Lancet 2:500-4, 1985.

DESMONTS, G.; REMINGTON, J.S. Direct agglutination test for diagnosis of

Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol 11:562-8, 1980.

DINIZ, E.M.A. Análise da evolução clínica e sorológica de RN portadores

de toxoplasmose congênita. São Paulo, 1984. Tese (Doutorado). Faculdade

de Medicina, Universidade de São Paulo.

DONDERS, G.G.; DESMYTER, J.; GOUBAU, P.; ASSCHE, F.A. Attitude towards serological tests for infection during pregnancy. Arch Gynecol Obstet 252:161-7, 1993.

DUPOUY-CAMET, J.; BOUGNOUX, M.E.; LAVAREDA DE SOUZA, S.; THULLIEZ, P.; DOMMERGUES, M.; MANDELBROT, L.; ANCELLE, T.; TOURTE-SCHAEFER, C.; BENAROUS, R. Comparative value of polymerase

chain reaction and conventional biological tests for the prenatal diagnosis of congenital toxoplasmosis. Ann Biol Clin 50:315-9, 1992.

FOULON, W. Congenital toxoplasmosis: is screening desirable?. Scand J

Infect Dis 84:11-7, 1992. Supplement.

FOULON, W.; NAESSENS, A.; LAUWERS, S.; DeMEUTER, F.; AMY, J. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy.

Obstet Gynecol 72:363-6, 1988.

GUIMARÃES, A.C.S.; KAWARABAYASHI, M.; BORGES, M,M,; TOLEZANO, J.E.; ANDRADE JR., H.F. Regional variation in toxoplasmosis seronegativity in the São Paulo metropolitan region. Rev Inst Med Trop São Paulo 35:479-83, 1993.

HALL, S.M. Congenital toxoplasmosis. [Review]. BMJ 305:291-7, 1992.

HALL, S.M. Diagnosing maternofetal toxoplasmosis. [Letter]. BMJ 302:1208, 1991.

HENRI, T.; JACQUES, S.; LAMBOTTE, R. Twenty-two years of screening for toxoplasmosis in pregnancy: Liège - Belgium. Scand J Infect Dis 84:84-5, 1992. Supplement.

HOHLFELD, P.; DAFFOS, F.; COSTA J.; THULLIEZ, Ph.; FORESTIER, F.; VIDAUD, M. Prenatal diagnosis of congenital toxoplasmosis with polymerase- chain-reaction test on amniotic fluid. N Engl J Med 331:695-9, 1994.

HOHLFELD, P.; DAFFOS, F.; THULLIEZ, P.; AUFRANT, C.; COUVREUR, J.; MAcALEESE, J.; DESCOMBEY, D.; FORESTIER, F. Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115:765-9, 1989.

HOLLIMAN, R.E. The diagnosis of toxoplasmosis. [Review]. Serodiag Imun

Infect Dis 4:83-93, 1990.

JANKU, J. Pathogenesa a pathologickà anatomie tak nazvanéko vrozeného kolobomu zluté skvrny v oku normálne velikém a mikrophthalmickém s nálezem parazitu v sítnici. Cas Lék Ces 62:1021-27,1054-9,1081-5, 1111-5,1138-44, 1923. (For English translation, see name author, Cesk Parasitol 6:9-58,1959.)

JAMRA, L.M.F. Contribuição para a epidemiologia da toxoplasmose.

Inquérito em 100 famílias de uma área da cidade de São Paulo. São Paulo,

1964. Tese (Doutorado) - Faculdade de Medicina, Universidade de São Paulo.

JEANNEL, D.; COSTAGLIOLA D.; NIEL, G.; HUBERT, B.; DANIS, M. what is known about the prevention of congenital toxoplasmosis?. [Comments].

JOSS, A.W.; CHATTERTON, J.M.; HO-YEN, D.O. Congenital toxoplasmosis: to screen or not to screen? Public Health 104:9-20, 1990.

JOYNSON, D.H. Epidemiology of toxoplasmosis in U.K. Scand J Infect Dis 84:65-9, 1992. Supplement.

JOYNSON, D.H.M.; PAYNE, R.A.; RAWAL, B.K. Potencial role of IgG avidity for diagnosing toxoplasmosis. J Clin Pathol 43:1032-3, 1990.

LAMB, G.A. ; FELDMAN, H.A. A nationwide serum survey of brazilian military recruits, 1964. III - Toxoplasmosis dye test antibodies. Amer J Epidemiol 87:323-8, 1968.

MATSUI, D. Prevention, diagnosis, and treatment of fetal toxoplasmosis. In:

Clinics in Perinatology . Philadelphia, Saunders, 1994. p. 675-89.

McCABE, R.; REMINGTON, J.S. [Editorial]. Toxoplasmosis: The time has come. N Engl J Med 318:313-5, 1988.

PEDREIRA, D.A.L ; CHA, S.C. Toxoplasmose. In: Medicina Fetal. 1. ed. São Paulo, Brasil: Atheneu, 1993. p. 297-300.

PEDREIRA, D.A.L., CAMARGO, M.; ANDRADE Jr., H.F.; SANTOS, V.A.; SADEK, L.; CHA, S.C. Diagnóstico intra-uterino da toxoplasmose congênita.

Anais 2o Encontro Nacional de Medicina fetal. Belo Horizonte, Brasil, 1994. p

10.

PEDREIRA, D.A.L.; WAISSMAN, T.; SANTOS, V.A.; CHA, S.C.; ZUGAIB, M. Perfil sorológico em gestantes de hospital universitário da grande São Paulo. In: Anais do 45o Congresso Brasileiro de Ginecologia e Obstetrícia. Salvador, Brasil, 1993. p. 215.

PINON, J.M.; TOUBAS, D.; MARX, C.;MOUGEOT, G.; BONNIN, A.; BONHOMME, A.;VILLAUME, M. FOUDRINIER, F.; LEPAN, H. Detection of specific immunoglobulin E in patients with toxoplasmosis. J Clin Microbiol 28:1739-43, 1990.

REMINGTON, J.S.; McLEOD, R.; DESMONTS, G. Toxoplasmosis. In: REMINGTON, J.S. ; KLEIN, J.O. Infectious diseases in the fetus and

newborn infant. 4. ed. Philadelphia, Saunders, 1995. p.140-267.

ROOS, T.; MARTIUS, J.; GROSS, U.; SCHROD, L. Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol 81:243-50, 1993.

ROTH, Ph.; MAILLET, R.; DALPHIN, M.L.; SCHAAL, J.P.; COLETTE, C. Toxoplasmosis and pregnancy: is it possible to simplify the diagnostic procedures? J Gynecol Obstet Biol Reprod 22:277-83, 1993.

SEVER, J.L. The importance of considering clinical usefulness in the evaluation of medical laboratory tests. [Letter]. Am J Obstet Gynecol 163:678-9, 1990.

STEPICK-BIEK, P.; THULLIEZ, P.; ARAUJO, F.G.; REMINGTON, J.S. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Inf

Dis 162:270-3, 1990.

STRAY-PEDERSEN, B. Toxoplasmosis in pregnancy. Baillières Clin Obstet

Gynaecol 7:107-37, 1993.

STRAY-PEDERSEN, B.; JENUM, P. Current status of toxoplasmosis in pregnancy in Norway. Scand J Infect Dis 84:80-3, 1992. Supplement.

STRAY-PEDERSEN, B.; JENUM, P. Economic evaluation of preventive programmes. Scand J Infect Dis 84:84-96, 1992. Supplement.

SUZUKI, Y.; THULLIEZ P.; DESMONTS, G.; REMINGTON, J.S. Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of toxoplasma infection in humans. J Clin Microbiol 26:901-5, 1988.

THULLIEZ, Ph.; DAFFOS, F.; FORESTIER, F. Diagnosis of toxoplasma infection in the pregnant woman and unborn child: Current problems. Scand J

Infect Dis 84:18, 1992. Supplement.

VAZ, A.J.; GUERRA, E.M.; FERRATTO, L.C.C.; TOLEDO, L.A.S.; AZEVEDO NETO, R.S. Sorologia positiva para sífilis, toxoplasmose e Doença de Chagas

em gestantes de primeira consulta em centros de saúde de área metropolitana, Brasil. Rev. Saúde Públ 24:373-9, 1990.

VIGGIANO, M.G.C.; MORAES FILHO, J.T.; OLIVEIRA, S.A.; AMARAL, W.N.; XIMENES, Y.R. Toxoplasmose congênita - A segunda infecção mais importante da síndrome STORCH. J Bras Ginec 101:293-302, 1991.

WALPOLE, I.R.; HODGEN, N.; BOWER, C. Congenital toxoplasmosis: a large survey in Western Australia. Med J Aust 154:720-4, 1991.

WILSON, C.B.; REMINGTON, J.S. What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol 138:357-63, 1980.

WONG, S.Y.; HAJDU, M.P.; RAMIREZ, R.; THULLIEZ, P.; McLEOD, R.; REMINGTON, J.S. Role of specific Immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis. J Clin Microbiol 31:2952-9, 1993.